ICU Medical, Inc. (ICUI)Healthcare | Medical Instruments & Supplies | San Clemente, United States | NasdaqGS
157.60 USD
+3.18
(2.059%)
⇧
(July 13, 2026, 4 p.m.
EDT)
After hours: 157.60 |
Hot Take ↕ | July 11, 2026, 4:41 a.m. EDT
ICUI presents a classic turnaround setup where the market is pricing in a massive earnings recovery, yet the underlying business metrics remain fragile. The stock has surged nearly 14% in the last two weeks, trading well above its 50-day and 200-day moving averages, which supports a bullish short-term outlook driven by technical momentum. However, the long-term picture is clouded by shrinking revenue of 12.3% and a paltry return on equity of just 2.26%. While the forward P/E of 16.6 suggests analysts expect a dramatic earnings pivot, the current profitability and growth rates do not yet justify a premium valuation. There is no dividend income to cushion the downside. Options activity shows a mix of hedging behavior with significant put open interest at lower strikes alongside substantial call open interest near current prices, indicating investors are protecting downside while betting on continued upside. The statistical forecast is too weak to guide the trade, so the decision rests on whether the earnings turnaround materializes. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.098352 |
| AutoETS | 0.101181 |
| AutoTheta | 0.128786 |
| AutoARIMA | 0.217442 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 40% |
| H-stat | 42.01 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.358 |
| Excess Kurtosis | -1.02 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 63.621 |
| Revenue per Share | 87.332 |
| Market Cap | 3,938,989,056 |
| Trailing P/E | 85.19 |
| Forward P/E | 16.94 |
| Beta | 0.76 |
| Profit Margins | 2.15% |
| Website | https://www.icumed.com |
As of July 11, 2026, 4:41 a.m. EDT: Speculators are hedging downside risk with significant put open interest at lower strikes (115-140) while maintaining bullish exposure via call open interest near current price levels (145-150). Implied volatility is elevated in the near term, suggesting uncertainty about the immediate path despite the recent rally.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.18012989 |
| Address1 | 951 Calle Amanecer |
| All Time High | 321.7 |
| All Time Low | 3.0 |
| Ask | 199.52 |
| Ask Size | 2 |
| Audit Risk | 5 |
| Average Analyst Rating | 1.6 - Buy |
| Average Daily Volume10 Day | 332,730 |
| Average Daily Volume3 Month | 298,955 |
| Average Volume | 298,955 |
| Average Volume10Days | 332,730 |
| Beta | 0.76 |
| Bid | 111.42 |
| Bid Size | 2 |
| Board Risk | 4 |
| Book Value | 84.501 |
| City | San Clemente |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 4 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 157.6 |
| Current Ratio | 2.343 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 157.64 |
| Day Low | 154.52 |
| Debt To Equity | 63.621 |
| Display Name | ICU Medical |
| Earnings Call Timestamp End | 1,778,185,800 |
| Earnings Call Timestamp Start | 1,778,185,800 |
| Earnings Timestamp | 1,778,184,000 |
| Earnings Timestamp End | 1,786,046,400 |
| Earnings Timestamp Start | 1,786,046,400 |
| Ebitda | 311,452,000 |
| Ebitda Margins | 0.14441 |
| Enterprise To Ebitda | 16.022 |
| Enterprise To Revenue | 2.314 |
| Enterprise Value | 4,989,933,056 |
| Eps Current Year | 8.1575 |
| Eps Forward | 9.3025 |
| Eps Trailing Twelve Months | 1.85 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 949 366 8368 |
| Fifty Day Average | 135.5692 |
| Fifty Day Average Change | 22.030807 |
| Fifty Day Average Change Percent | 0.162506 |
| Fifty Two Week Change Percent | 18.012989 |
| Fifty Two Week High | 162.18 |
| Fifty Two Week High Change | -4.5799866 |
| Fifty Two Week High Change Percent | -0.028240146 |
| Fifty Two Week Low | 107.0 |
| Fifty Two Week Low Change | 50.600006 |
| Fifty Two Week Low Change Percent | 0.47289726 |
| Fifty Two Week Range | 107.0 - 162.18 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 702,052,200,000 |
| Float Shares | 24,505,460 |
| Forward Eps | 9.3025 |
| Forward P E | 16.941683 |
| Free Cashflow | 387,079,616 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 13,000 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.37934 |
| Gross Profits | 818,156,032 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.01918 |
| Held Percent Institutions | 1.14922 |
| Implied Shares Outstanding | 24,993,585 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Ir Website | http://ir.icumed.com/ |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,016,409,600 |
| Last Split Factor | 3:2 |
| Long Business Summary | ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California. |
| Long Name | ICU Medical, Inc. |
| Market | us_market |
| Market Cap | 3,938,989,056 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_317440 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | 46,340,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 3,861,758,818 |
| Number Of Analyst Opinions | 8 |
| Open | 154.52 |
| Operating Cashflow | 167,428,992 |
| Operating Margins | 0.0573 |
| Overall Risk | 4 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.09 |
| Phone | 949 366 2183 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 157.6 |
| Post Market Time | 1,783,981,119 |
| Previous Close | 154.42 |
| Price Eps Current Year | 19.319645 |
| Price Hint | 2 |
| Price To Book | 1.8650668 |
| Price To Sales Trailing12 Months | 1.8263245 |
| Profit Margins | 0.02149 |
| Quick Ratio | 0.953 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.625 |
| Region | US |
| Regular Market Change | 3.18001 |
| Regular Market Change Percent | 2.05932 |
| Regular Market Day High | 157.64 |
| Regular Market Day Low | 154.52 |
| Regular Market Day Range | 154.52 - 157.64 |
| Regular Market Open | 154.52 |
| Regular Market Previous Close | 154.42 |
| Regular Market Price | 157.6 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 153,435 |
| Return On Assets | 0.01679 |
| Return On Equity | 0.02261 |
| Revenue Growth | -0.123 |
| Revenue Per Share | 87.332 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 5 |
| Shares Outstanding | 24,993,585 |
| Shares Percent Shares Out | 0.0674 |
| Shares Short | 1,685,563 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 1,837,896 |
| Short Name | ICU Medical, Inc. |
| Short Percent Of Float | 0.0808 |
| Short Ratio | 5.36 |
| Source Interval | 15 |
| State | CA |
| Symbol | ICUI |
| Target High Price | 200.0 |
| Target Low Price | 160.0 |
| Target Mean Price | 172.5 |
| Target Median Price | 167.5 |
| Total Cash | 292,676,000 |
| Total Cash Per Share | 11.71 |
| Total Debt | 1,343,619,968 |
| Total Revenue | 2,156,784,896 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 1.85 |
| Trailing P E | 85.18919 |
| Trailing Peg Ratio | 0.0877 |
| Triggerable | 1 |
| Two Hundred Day Average | 136.1807 |
| Two Hundred Day Average Change | 21.419312 |
| Two Hundred Day Average Change Percent | 0.15728596 |
| Type Disp | Equity |
| Volume | 153,435 |
| Website | https://www.icumed.com |
| Zip | 92,673 |